We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Eyenuk’s EyeArt artificial intelligence (AI) system had a sensitivity of 96.4 percent in identifying more than mild diabetic retinopathy (mtmDR) while dilation eye exams had a 27.7 percent sensitivity in the identical study group, researchers reported at the American Academy of Ophthalmology's annual meeting in Chicago. Read More
Patients using Beta Bionics’ iLet Bionic Pancreas had an average lower blood glucose level and 11 percent more time in the target blood sugar range, according to study results published in the New England Journal of Medicine (NEJM).Read More
Six EU countries have turned up the heat on medical product sponsors who haven’t shared the findings of their clinical trials, with significant success, a new analysis finds. Read More
Pulnovo Medical reported positive results for its radiofrequency device for pulmonary arterial hypertension (PAH) in a presentation at the Transcatheter Cardiovascular Therapeutics annual scientific symposium in Boston, Mass. Read More
The Regeneten Biodinductive Implant from Britain’s Smith+Nephew delivered an 86 percent reduction in rotator cuff re-tear rates at 12 months, according to interim study results presented at a conference last week in Dublin. Read More
New research published in the NEJM Evidence shows potential for Nordic Bioscience’s PRO-C6 assay becoming a next-generation biomarker in trials studying patients with heart failure with preserved ejection fraction (HFpEF). Read More
All people are not the same. While glaringly obvious, that truth is often ignored in clinical trials. And fixing that problem requires companies to understand and overcome a myriad of barriers, according to a panel discussion held at the annual meeting of the Regulatory Affairs Professionals Society (RAPS) in Phoenix this week. Read More
South Korea’s Lunit INSIGHT CXR artificial intelligence (AI) system improved radiologists’ findings in chest X-rays in four abnormalities, according to study findings published in JAMA Network Open on Aug. 31. Read More
Three-year results continue to show that Abbott’s Amplatzer Piccolo Occluder, which was approved by the FDA in 2019, is safe and effective in nonsurgically closing a hole in the heart of premature infants. Read More